Trial
NCT00167206
Stem Cell Transplantation for Fanconi Anemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Fanconi Anemia
Intervention
Hematopoietic Stem Cell Transplant
Why stopped
Treatment with thymic shielding found safe, another study started.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-26